General Information of the Compound
| Compound ID |
CP0510099
|
||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Compound Name |
2-(4-(2-(9-((2R,3R,4S,5S)-3,4-dihydroxy-5-propionamidotetrahydrofuran-2-yl)-6-(2,2-diphenylethylamino)-9H-purin-2-ylamino)ethyl)-1H-imidazol-1-yl)acetic acid
Show/Hide
|
||||||||||||||||||
| Structure |
|
||||||||||||||||||
| Formula |
C34H39N9O5
|
||||||||||||||||||
| Molecular Weight |
653.744
|
||||||||||||||||||
| Canonical SMILES |
CCC(=O)N[C@H]1C[C@H]([C@H](O)[C@@H]1O)n1cnc2c(NCC(c3ccccc3)c3ccccc3)nc(NCCc3cn(CC(O)=O)cn3)nc12
Show/Hide
|
||||||||||||||||||
| InChI |
InChI=1S/C34H39N9O5/c1-2-27(44)39-25-15-26(31(48)30(25)47)43-20-38-29-32(36-16-24(21-9-5-3-6-10-21)22-11-7-4-8-12-22)40-34(41-33(29)43)35-14-13-23-17-42(19-37-23)18-28(45)46/h3-12,17,19-20,24-26,30-31,47-48H,2,13-16,18H2,1H3,(H,39,44)(H,45,46)(H2,35,36,40,41)/t25-,26+,30+,31-/m0/s1
Show/Hide
|
||||||||||||||||||
| InChIKey |
SLUDEWSSMYOKIL-ZBKRMGPDSA-N
|
||||||||||||||||||
| Physicochemical Property |
"RO5" indicates the cutoff set by lipinski's rule of five: (1) Molecular weight less than 500 Dalton; (2) xlogp less than 5; (3) No more than 5 hbonddonor (Hydrogen Bond Donor Count); (4) No more than 10 hbondacc (Hydrogen Bond Acceptor Count); (5) No more than 10 rotbonds (Rotatable Bond Count). Show/Hide
|
||||||||||||||||||
| Click to Show/Hide the External Link(s) of This Compound | |||||||||||||||||||
| PubChem ID | |||||||||||||||||||
| ChEMBL ID | |||||||||||||||||||
Map of Molecular Bioactivity Related to the Compound
|
Map of Molecular Bioactivity Related to the Compound Compound Cell Line Protein Bioactivity Value: <= 0.1 μM > 0.1 μM and <= 10 μM > 10 μM Imprecise Activity |
|
|---|
Table of Molecular Bioactivities Related to the Compound